Clark A L, Sparrow J L, Coats A J
Department of Cardiac Medicine, National Heart and Lung Institute, London, U.K.
Eur Heart J. 1995 Jan;16(1):49-52. doi: 10.1093/eurheartj/16.1.49.
The pathogenesis of the limiting symptoms in patients with chronic heart failure, shortness of breath and fatigue on exercise, are poorly understood. We analysed data from 222 incremental symptom limited exercise tests to determine whether there were differences between patients stopped by breathlessness or fatigue. One hundred and sixty patients were stopped by breathlessness and 62 by fatigue. There was no differences between the two groups in underlying diagnosis or in exercise performance (peak oxygen consumption 15.66 (+/- 5.62) ml.kg-1.min-1 in the fatigue group, 15.13 (+/- 4.64) in the breathless group). The ventilatory response as assessed by ventilatory response to carbon dioxide production (VE/VCO2 slope) was not different between the two groups (2.61 (+/- 0.96) in the fatigue group, 3.03 (+/- 1.23) in the breathless group: P = ns). There were no differences between the two groups in left ventricular dimensions, left ventricular ejection fraction or left ventricular end-diastolic pressure. The limiting symptoms of breathlessness and fatigue in chronic heart failure are two sides of the same coin. Any pathophysiological explanation of exercise limitation in chronic heart failure must unify these two symptoms.
慢性心力衰竭患者出现运动时呼吸急促和疲劳等限制症状的发病机制,目前了解甚少。我们分析了222例递增症状限制运动试验的数据,以确定因呼吸急促或疲劳而终止运动的患者之间是否存在差异。160例患者因呼吸急促而终止运动,62例因疲劳而终止运动。两组在基础诊断或运动表现方面(疲劳组的峰值耗氧量为15.66(±5.62)ml·kg⁻¹·min⁻¹,呼吸急促组为15.13(±4.64))无差异。通过二氧化碳产生的通气反应评估的通气反应(VE/VCO₂斜率)在两组之间也无差异(疲劳组为2.61(±0.96),呼吸急促组为3.03(±1.23):P =无显著性差异)。两组在左心室大小、左心室射血分数或左心室舒张末期压力方面无差异。慢性心力衰竭中呼吸急促和疲劳的限制症状是同一问题的两个方面。任何关于慢性心力衰竭运动受限的病理生理学解释都必须将这两种症状统一起来。